These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8086608)

  • 1. A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
    Gray RJ
    Biometrics; 1994 Mar; 50(1):244-53. PubMed ID: 8086608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment of recurrent small-cell lung cancer.
    Hosp Med; 1999 Mar; 60(3):220. PubMed ID: 10476252
    [No Abstract]   [Full Text] [Related]  

  • 3. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for cure of small cell bronchial carcinoma (SCLC) at early stages and postoperative combined modality treatment.
    Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Erzen J; Salzer GM;
    J Chemother; 1989 Jul; 1(4 Suppl):1207-8. PubMed ID: 16312836
    [No Abstract]   [Full Text] [Related]  

  • 7. Bayesian variable selection method for censored survival data.
    Faraggi D; Simon R
    Biometrics; 1998 Dec; 54(4):1475-85. PubMed ID: 9883546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
    Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
    Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of small cell lung cancer].
    Komiya T; Takada M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etoposide in the treatment of small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large hierarchical Bayesian analysis of multivariate survival data.
    Gustafson P
    Biometrics; 1997 Mar; 53(1):230-42. PubMed ID: 9147593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
    Bregni M; Pedrazzoli P
    J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
    [No Abstract]   [Full Text] [Related]  

  • 16. Sample sizes for cancer trials where Health Related Quality of Life is the primary outcome.
    Julious SA; Campbell MJ; Walker SJ; George SL; Machin D
    Br J Cancer; 2000 Oct; 83(7):959-63. PubMed ID: 10970702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and treatment effect heterogeneity for survival times between centers using a random effects accelerated failure time model with flexible error distribution.
    Komárek A; Lesaffre E; Legrand C
    Stat Med; 2007 Dec; 26(30):5457-72. PubMed ID: 17910009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy of lung cancer].
    Yamaguchi Y; Urabe N; Momiki S; Obata S; Ogawa T; Kimura H
    Rinsho Kyobu Geka; 1987; 7(5):448-52. PubMed ID: 9301798
    [No Abstract]   [Full Text] [Related]  

  • 19. A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model.
    Legrand C; Ducrocq V; Janssen P; Sylvester R; Duchateau L
    Stat Med; 2005 Dec; 24(24):3789-804. PubMed ID: 16320274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.